Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.7020
+0.0854 (13.85%)
At close: Jun 26, 2026, 4:00 PM EDT
0.7400
+0.0380 (5.41%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Vistagen Therapeutics Employees
Vistagen Therapeutics had 41 employees as of March 31, 2026. The number of employees decreased by 16 or -28.07% compared to the previous year.
Employees
41
Change
-16
Growth
-28.07%
Revenue / Employee
$30,951
Profits / Employee
-$1,699,634
Market Cap
28.80M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| Quantum BioPharma | 17 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Serina Therapeutics | 16 |
| Neuphoria Therapeutics | 8 |
VTGN News
- 11 days ago - Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate Update - Business Wire
- 11 days ago - Vistagen Therapeutics Earnings release: Q4 2026 - Filings
- 11 days ago - Vistagen Therapeutics Annual report: Q4 2026 - Filings
- 17 days ago - Vistagen announces fasedienol achieves minimum patient exposures - TheFly
- 17 days ago - Vistagen Achieves Minimum ICH Safety Exposure Recommendations Across Clinical Program for Fasedienol for the Acute Treatment of Social Anxiety Disorder - Business Wire
- 4 weeks ago - Vistagen to Participate in Jefferies 2026 Global Healthcare Conference - Business Wire
- 5 weeks ago - Vistagen Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Vistagen appoints Angelov as Chief Medical Officer - TheFly